Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
sergio.valente@uniroma1.it
Sergio Valente
Professore Associato
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
sergio.valente@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene
HUMAN GENETICS
2020
Discovery of the first human arylsulfatase a reversible inhibitor impairing mouse oocyte fertilization
ACS CHEMICAL BIOLOGY
2020
Design of first-in-class dual EZH2/HDAC inhibitor: biochemical activity and biological evaluation in cancer cells
ACS MEDICINAL CHEMISTRY LETTERS
2020
The innovative potential of statins in cancer: new targets for new therapies
FRONTIERS IN CHEMISTRY
2020
Properly substituted cyclic Bis-(2-bromobenzylidene) compounds behaved as dual p300/CARM1 Inhibitors and Induced apoptosis in cancer cells
MOLECULES
2020
CDK9 as a valuable target in cancer: from natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas
FRONTIERS IN PHARMACOLOGY
2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity
CHEMMEDCHEM
2020
Identification of novel quinazoline derivatives as potent antiplasmodial agents
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2019
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
CLINICAL EPIGENETICS
2019
Sirtuins as drug targets
Epigenetic Drug Discovery
2019
Epigenetic Pharmacology in Regenerative Medicine (Epi-Drugs)
Epigenetics and Regeneration
2019
Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype
CLINICAL EPIGENETICS
2019
Lysine methyltransferases and their inhibitors
Chemical Epigenetics
2019
The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cells
SCIENTIFIC REPORTS
2019
Histone deacetylases contribute to excitotoxicity-triggered degeneration of retinal ganglion cells in vivo
MOLECULAR NEUROBIOLOGY
2019
Statins and histone deacetylase inhibitors affect lamin A/C - histone deacetylase 2 interaction in human cells
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
2019
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer
CURRENT OPINION IN CHEMICAL BIOLOGY
2019
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
NATURE COMMUNICATIONS
2018
HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal
OPEN ACCESS SCIENTIFIC REPORTS
2018
« prima
< precedente
1
2
3
4
5
seguente ›
ultima »
Progetti di Ricerca
Design and biological evaluation of novel epigenetic dual-targeting modulators to fight cancer
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma